Retina Associates of Cleveland

Cleveland, Ohio 44195

1 studies enrolling now · 20 studies all time

What they study most

Age-related Macular Degeneration, Cataract, Central Retinal Vein Occlusion, Depression, Diabetic Retinopathy, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Geographic Atrophy of the Macula, Idiopathic Juxtafoveal Telangiectasia, Macular Degeneration, Macular Edema, Macular Neovascularization Secondary to Age-Related Macular Degeneration

Studies at this site

• A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio — Recruiting now
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Running, not enrolling
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy — Completed
• A Study of NGM621 in Participants With Geographic Atrophy — Completed
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. — Stopped early
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) — Completed
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
• Serine and Fenofibrate Study in Patients With MacTel Type 2 — Running, not enrolling
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy — Completed
• Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel) — Completed
• Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole — Completed
• Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD) — Completed
• Age-Related Eye Disease Study 2 (AREDS2) — Completed
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage — Completed
• Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion — Status unconfirmed
• Complications of Age-Related Macular Degeneration Prevention Trial — Completed